HIV Progression to AIDS: Understanding the Natural History & ART Impact

HIV infection progresses through stages; AIDS is the advanced, immunocompromised stage. There is no reversion from AIDS to HIV—only viral suppression with treatment.

Natural History (Untreated)

AIDS-Defining Criteria (CDC)

  • CD4+ T-cells <200 cells/μL or <14% of lymphocytes.
  • Any Category C condition (PCP, toxo encephalitis, CMV retinitis, MAC, cryptococcal meningitis, esophageal candidiasis, Kaposi sarcoma, NHL, invasive cervical cancer, wasting syndrome, etc.).

Antiretroviral Therapy (ART) Changes the Trajectory

  • Goal: Viral suppression (<50 copies/mL, ideally <20).
  • Mechanism: Combination (≥3 drugs, 2 classes) blocks replication at multiple steps.
  • Outcomes:
    • CD4 recovery (immune reconstitution).
    • Prevention of OIs.
    • Near-normal life expectancy if started early and adhered to.
    • U=U (Undetectable = Untransmittable): Zero sexual transmission risk when virally suppressed.

Critical Concepts

  • No cure: HIV integrates into host genome (latent reservoir). ART suppresses, doesn't eradicate.
  • Adherence is lifelong: Interruption → rebound viremia, resistance, CD4 decline.
  • "AIDS" is a clinical stage, not a separate virus. A person with AIDS on effective ART can regain CD4 >500 and remain healthy, but still has HIV.
  • Cure research: "Shock and kill," gene editing (CRISPR), broadly neutralizing antibodies, therapeutic vaccines – experimental.

Monitoring on ART

  • Viral load: baseline, 4–8 weeks, then q3–4mo until suppressed, then q6mo.
  • CD4: baseline, q3–6mo until >500, then optional.
  • Metabolic/toxicity labs per regimen.

HIV & AIDS - Related Articles

Health Sciences © https://www.222health.com

StageCD4 CountClinical FeaturesDuration
Acute seroconversion>500Flu-like illness, high viremia2–4 weeks
Clinical latency500–350Asymptomatic; slow CD4 decline (~50–80/yr)8–10 years (median)
Symptomatic HIV350–200Oral thrush, shingles, constitutional symptomsVariable
AIDS<200 or OIOpportunistic infections, malignancies, wastingWithout ART: fatal